The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19.
Marcos Pereira;
Enny Paixão 
;
Anete Trajman;
Ramon Andrade de Souza;
Marcio Santos da Natividade;
Julia M Pescarini ;
Susan Martins Pereira;
Florisneide Rodrigues Barreto;
Ricardo Ximenes;
Margareth Dalcomo;
+4 more...
Maria Yury Ichihara;
Ceuci Nunes;
Manoel Barral-Netto;
Maurício L Barreto;
(2020)
The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19.
RESPIRATORY RESEARCH, 21 (1).
178-.
ISSN 1465-9921
DOI: 10.1186/s12931-020-01439-4
;
Anete Trajman;
Ramon Andrade de Souza;
Marcio Santos da Natividade;
Julia M Pescarini ;
Susan Martins Pereira;
Florisneide Rodrigues Barreto;
Ricardo Ximenes;
Margareth Dalcomo;
+4 more...
Maria Yury Ichihara;
Ceuci Nunes;
Manoel Barral-Netto;
Maurício L Barreto;
(2020)
The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19.
RESPIRATORY RESEARCH, 21 (1).
178-.
ISSN 1465-9921
DOI: 10.1186/s12931-020-01439-4
Bacillus Calmette-Guérin (BCG) vaccination is routine and near-universal in many low- and middle-income countries (LMIC). It has been suggested that BCG can have a protective effect on COVID-19 morbidity and mortality. This commentary discusses the limitations of the evidence around BCG and COVID-19. We argue that higher-quality evidence is necessary to understand the protective effect of the BCG vaccine from existing, secondary data, while we await results from clinical trials currently conducted in different settings.
-
picture_as_pdf - The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19.pdf
-
subject - Published Version
-
- Available under Creative Commons: NC-ND 3.0
Downloads